V008-0025 Screening compound: N-[1-(3-methylphenyl)-4-phenyl-1H-imidazol-2-yl]-2-{N-[(oxolan-2-yl)methyl]-2-phenylacetamido}acetamide

V008-0025 Screening compound: N-[1-(3-methylphenyl)-4-phenyl-1H-imidazol-2-yl]-2-{N-[(oxolan-2-yl)methyl]-2-phenylacetamido}acetamide
V008-0025 Screening compound: N-[1-(3-methylphenyl)-4-phenyl-1H-imidazol-2-yl]-2-{N-[(oxolan-2-yl)methyl]-2-phenylacetamido}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V008-0025
N-[1-(3-methylphenyl)-4-phenyl-1H-imidazol-2-yl]-2-{N-[(oxolan-2-yl)methyl]-2-phenylacetamido}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V008-0025

Molecular Formula

C31H32N4O3 (C31 H32 N4 O3)

Compound Name

N-[1-(3-methylphenyl)-4-phenyl-1H-imidazol-2-yl]-2-{N-[(oxolan-2-yl)methyl]-2-phenylacetamido}acetamide

IUPAC name

N-[1-(3-methylphenyl)-4-phenyl-1H-imidazol-2-yl]-2-{N-[(oxolan-2-yl)methyl]-2-phenylacetamido}acetamide

SMILES

Cc1cccc(-n2c(NC(CN(CC3OCCC3)C(Cc3ccccc3)=O)=O)nc(-c3ccccc3)c2)c1

InChI

InChI=1S/C31H32N4O3/c1-23-10-8-15-26(18-23)35-21-28(25-13-6-3-7-14-25)32-31(35)33-29(36)22-34(20-27-16-9-17-38-27)30(37)19-24-11-4-2-5-12-24/h2-8,10-15,18,21,27H,9,16-17,19-20,22H2,1H3,(H,32,33,36)/t27-/m1/s1

InChI Key

IJHHIFBLAXBVQM-HHHXNRCGSA-N

MDL Number (MFCD)

MFCD19821730

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

508.62

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.323

Distribution Coefficient, logD

5.323

Water Solubility, LogSw

-5.09

Polar Surface Area

60.520

Acid Dissociation Constant (pKa)

13.59

Base Dissociation Constant (pKb)

3.46

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

25.80

V008-0025 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • GPCR
  • Proteases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V008-0025 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V008-0025?
Check Price and Availability of V008-0025, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V008-0025 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V008-0025
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V008-0025
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V008-0025 available by request